Vliyanie amilina na funktsiyu beta-kletok i regulyatsiyu uglevodnogo obmena
https://doi.org/10.14341/2072-0351-5584
Abstract
References
1. Rocken C et al.(1992) Arch Pathol Anat Histopathol 421:339-344.
2. Сlark A. et al. (1988) Diabetes Res Clin Prac 9:151-159.
3. Harrison's principles of Internal Medicine 16-th Edition Dennis L.Kasper et al. pp. 2024-2029.
4. Opie E. (1901) The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of islands of Langerhans. J Exp Med 5: 527-540.
5. Kapourniotu A. et al. Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide. Eur J Biochem 251: 208-216.
6. Gedulin B. et al. Amylin inhibition of arginine-induced glucagons secretion/ Diabetologia 1996; 39: 154-166.
7. Jodka C., Green D., Yuong A. Amylin modulation of gastric empting in rats depends an intact vagus nerve. Diabetes 45; A235, 1996.
8. Bretherton D. et al. Failure to establish islet amyloid polypeptide as a circulating beta cell inhibiting hormone in man. Diabetologia 33: 115-117, 1990.
9. Bretherton D. Very high concentrations of amylin are necessary to alter the insulin response to intravenous glucose in man. J Clin Endocrin Metab 74: 1032-1035, 1992.
10. Wilding J. et al. Lack of acute effect of amylin on insulin sensitivity during hyperinsulinemic euglycemic clamp in humans. Diabetologia 37: 166-169, 1994.
11. Colburn W. et. al. Pharmacokinetics and pharmacodynamics of AC137 after intravenous bolus and infusion doses in patients with insulin-dependent diabetes. J Clin Pharmacol 36: 13-24, 1996.
Review
For citations:
Galstyan G.R. Vliyanie amilina na funktsiyu beta-kletok i regulyatsiyu uglevodnogo obmena. Diabetes mellitus. 2008;11(4):24-25. https://doi.org/10.14341/2072-0351-5584
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
